Business Context and Reporting Period
This Form 8-K filing by NanoViricides, Inc. reports on the results of the Company's 2013 Annual Meeting of Stockholders held on December 9, 2013. The report was filed on December 11, 2013. The Company is incorporated in Nevada and maintains its principal executive offices in West Haven, Connecticut.
Key Financial Metrics
This filing is a current report regarding corporate governance and voting results. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes and Voting Results
The primary material event reported is the outcome of four proposals voted upon by stockholders. Approximately 89% of the Company's outstanding voting capital stock was present in person or by proxy.
- Proposal 1 (Director Election): Eugene Seymour was re-elected as a Class II director for a two-year term.
- Votes For: 44,255,977
- Votes Against: 0
- Votes Withheld: 281,490
- Proposal 2 (Say-on-Pay): Advisory vote on executive compensation was approved.
- Votes For: 44,086,009
- Votes Against: 229,312
- Votes Abstained: 207,860
- Proposal 3 (Say-on-Frequency): Stockholders voted to approve executive compensation on a three-year frequency.
- Votes For: 41,319,754
- Votes Against: 3,063,582
- Votes Abstained: 154,131
- Proposal 4 (Auditor Ratification): The appointment of Li & Company, P.C. as the independent registered public accounting firm for the fiscal year ending June 30, 2014, was ratified.
- Votes For: 52,339,707
- Votes Against: 330,249
- Votes Abstained: 563,497
Guidance, Outlook, and Risks
The filing does not provide management guidance, financial outlook, or specific risk factors. It references a press release issued on December 10, 2013, regarding the meeting results, but does not include the text of that release or any forward-looking statements within this document.
Investor Verification Checklist
- Verify the Company's financial health and liquidity status by reviewing the most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Confirm the tenure of Eugene Seymour as a director through the 2015 annual meeting.
- Review the Proxy Statement filed on October 22, 2013, for detailed descriptions of the proposals and executive compensation specifics.
- Monitor future filings for the appointment of the independent auditor for the fiscal year ending June 30, 2014.